CUROGEN attended the 45th TD Cowen Health Care Conference held during March 3–5, 2025 in Boston. 

The conference served as a valuable platform for investor engagement, during which our team held a series of one-on-one meetings with global healthcare investors. We shared recent progress across our pipeline, outlined our strategic vision in immunology and autoimmune diseases, and explored opportunities for future growth.

We appreciate the interest and thoughtful discussions from the investor community and look forward to ongoing dialogue as we continue advancing our mission to develop transformative therapies.